0001209191-19-048075.txt : 20190904
0001209191-19-048075.hdr.sgml : 20190904
20190904131846
ACCESSION NUMBER: 0001209191-19-048075
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190901
FILED AS OF DATE: 20190904
DATE AS OF CHANGE: 20190904
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knickerbocker Aron Marc
CENTRAL INDEX KEY: 0001578766
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 191073884
MAIL ADDRESS:
STREET 1: C/O FIVE PRIME THERAPEUTICS, INC.
STREET 2: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
DATE OF NAME CHANGE: 20020613
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-01
0
0001175505
FIVE PRIME THERAPEUTICS, INC.
FPRX
0001578766
Knickerbocker Aron Marc
111 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President & CEO
Common Stock
2019-09-01
4
F
0
3306
5.43
D
42057
D
Common Stock
200299
I
By the Aron M. Knickerbocker Revocable Trust
Since the date of the reporting person's last ownership report, he transferred 2,848 shares of common stock to the Aron M. Knickerbocker Revocable Trust.
Includes 1,623 shares acquired on May 15, 2019 pursuant to Five Prime Therapeutics, Inc.'s 2013 Employee Stock Purchase Plan.
/s/ Francis Sarena, Attorney-in-fact
2019-09-04